Imprimir…

Esta buscando: Ácido+metilfosfónico


51 617  results were found

Refinar resultados Ordenado por

Sort Results

Vista lista Vista Extendida (Nueva)
SearchResultCount:"51617"

Valore los resultados de su búsqueda

Image Unavailable-BOSSBS-11800R-CY7

Anti-AVPR1B Rabbit Polyclonal Antibody (Cy7®)

Descripción: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Numero del catalogo: BOSSBS-11800R-CY7
UOM: 1 * 100 µl
Proveedor: Bioss
Image Unavailable-J16285.36

L(+)-Glutamina ≥98.5%, grado ultrapuro

Descripción: L(+)-Glutamina ≥98.5%, grado ultrapuro
Numero del catalogo: J16285.36
UOM: 1 * 500 g
Proveedor: Thermo Fisher Scientific
Image Unavailable-1.07647.9010

L(+)-Serina, EMPROVE® EXPERT Ph. Eur., USP suitable for use as excipient, SAFC®

Descripción: L(+)-Serina, EMPROVE® EXPERT Ph. Eur., USP suitable for use as excipient, SAFC®
Numero del catalogo: 1.07647.9010
UOM: 1 * 10 kg
Proveedor: MERCK PRODUCTION CHEMICALS
Image Unavailable-90070.

CBQCA

Descripción: CBQCA (3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde) reacts specifically with primary amines to form conjugates that can be analyzed by electrophoretic or chromatographic methods. CBQCA also reacts with hydrophilic peptides and amino sugars. The amine derivatized product (7-aza-1-cyano-5,6-benzisoindole) is highly fluorescent that is optimally excited at 450 nm and have emission maximum at 560 nm.
Numero del catalogo: 90070.
UOM: 1 * 10 mg
Proveedor: Biotium
Image Unavailable-J60573.14

L(+)-Glutamina cell culture reagent

Descripción: L(+)-Glutamina cell culture reagent
Numero del catalogo: J60573.14
UOM: 1 * 25 g
Proveedor: Thermo Fisher Scientific

FDS Certificados


Image Unavailable-EHERC14034450

L(+)-Glutamina

Descripción: L(+)-Glutamina
Numero del catalogo: EHERC14034450
UOM: 1 * 0,1 g
Proveedor: EHRENSTORFER
Product Image-AATB611

5-(2-Aminoethylamino)-1-naphthalenesulphonic acid ≥95%

Descripción: EDANS is one of the most popular donors for developing FRET-based nucleic acid probes (such as Molecular Beacons) and protease substrates.
Numero del catalogo: AATB611
UOM: 1 * 10 g
Proveedor: AAT BIOQUEST
Product Image-AATB610

5-(2-Aminoethylamino)-1-naphthalenesulphonic acid ≥95%

Descripción: EDANS is one of the most popular donors for developing FRET-based nucleic acid probes (such as molecular beacons) and protease substrates.
Numero del catalogo: AATB610
UOM: 1 * 1 g
Proveedor: AAT BIOQUEST
Image Unavailable-BOSSBS-11800R-FITC

Anti-AVPR1B Rabbit Polyclonal Antibody (FITC (Fluorescein Isothiocyanate))

Descripción: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Numero del catalogo: BOSSBS-11800R-FITC
UOM: 1 * 100 µl
Proveedor: Bioss
Image Unavailable-BOSSBS-11800R-HRP

Anti-AVPR1B Rabbit Polyclonal Antibody (HRP (Horseradish Peroxidase))

Descripción: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Numero del catalogo: BOSSBS-11800R-HRP
UOM: 1 * 100 µl
Proveedor: Bioss
Image Unavailable-BOSSBS-11800R-A680

Anti-AVPR1B/AVP Receptor V3 Rabbit Polyclonal Antibody (Alexa Fluor® 680)

Descripción: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterised by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumours (2).
Numero del catalogo: BOSSBS-11800R-A680
UOM: 1 * 100 µl
Proveedor: Bioss
Image Unavailable-BOSSBS-11800R-A350

Anti-AVPR1B Rabbit Polyclonal Antibody (Alexa Fluor® 350)

Descripción: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Numero del catalogo: BOSSBS-11800R-A350
UOM: 1 * 100 µl
Proveedor: Bioss
Image Unavailable-ICNA091680149

L(+)-Glutamina

Descripción: L(+)-Glutamina
Numero del catalogo: ICNA091680149
UOM: 1 * 100 mL
Proveedor: MP Biomedicals
Image Unavailable-RC-054

Glicina

Descripción: Glicina
Numero del catalogo: RC-054
UOM: 1 * 500 g
Proveedor: G-Biosciences
Image Unavailable-357002-1

Glicina, Millipore®

Descripción: Glicina, Millipore®
Numero del catalogo: 357002-1
UOM: 1 * 1 kg
Proveedor: Merck Millipore (Calbiochem‎)
Image Unavailable-EHERCA17588000

Tobramicina

Descripción: Tobramicina
Numero del catalogo: EHERCA17588000
UOM: 1 * 0,1 g
Proveedor: EHRENSTORFER
977 - 992 of 51 617